BioNTech Wants To 'Eradicate' Malaria With mRNA Vaccine

BioNTech Wants To 'Eradicate' Malaria With mRNA Vaccine

The German pharmaceutical company aims to start trialing a malaria shot next year using the same breakthrough mRNA technology.

Andrew H. Sweet

If successful, the shot could be a major development in the fight against malaria, which kills more than 400,000 people a year — mainly young children in Africa.

The disease is caused by a parasite that commonly infects a certain type of mosquito which feeds on humans.

Scientists believe mRNA technology, which prompts an immune response by delivering genetic molecules containing the code for key parts of a pathogen into human cells, could be a game-changer against several diseases.

Using this technology is also a faster way of developing a vaccine than traditional methods and could bring an end to the decades-long search for a reliable malaria shot.

Read the original story here.


Sign in or become a tippinsights member to join the conversation.
Just enter your email below to get a log in link.